These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8120401)

  • 1. Deletion and editing of B cells that express antibodies to DNA.
    Chen C; Radic MZ; Erikson J; Camper SA; Litwin S; Hardy RR; Weigert M
    J Immunol; 1994 Feb; 152(4):1970-82. PubMed ID: 8120401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of VH CDR3 arginine and light chain pairing on DNA reactivity of a bacterial DNA-induced anti-DNA antibody from a BALB/c mouse.
    Wloch MK; Clarke SH; Gilkeson GS
    J Immunol; 1997 Dec; 159(12):6083-90. PubMed ID: 9550408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sm and DNA binding by dual reactive B cells requires distinct VH, V kappa, and VH CDR3 structures.
    Retter MW; Eisenberg RA; Cohen PL; Clarke SH
    J Immunol; 1995 Aug; 155(4):2248-57. PubMed ID: 7636271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. Differences from spontaneous anti-DNA in the content and location of VH CDR3 arginines.
    Gilkeson GS; Bloom DD; Pisetsky DS; Clarke SH
    J Immunol; 1993 Aug; 151(3):1353-64. PubMed ID: 8335932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light chain contribution to specificity in anti-DNA antibodies.
    Ibrahim SM; Weigert M; Basu C; Erikson J; Radic MZ
    J Immunol; 1995 Sep; 155(6):3223-33. PubMed ID: 7673735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoreactive anti-DNA transgenic B cells in lupus-prone New Zealand black/New Zealand white mice show near perfect L chain allelic exclusion.
    Makdasi E; Fischel R; Kat I; Eilat D
    J Immunol; 2009 May; 182(10):6143-8. PubMed ID: 19414767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repertoire diversification in mice with an IgH-locus-targeted transgene for the rearranged VH domain of a physiologically selected anti-ssDNA antibody.
    Li J; Geissal ED; Li W; Stollar BD
    Mol Immunol; 2005 Aug; 42(12):1475-84. PubMed ID: 15950740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the amino acid position of arginine in VH-CDR3 and specificity for native DNA among autoimmune antibodies.
    Krishnan MR; Jou NT; Marion TN
    J Immunol; 1996 Sep; 157(6):2430-9. PubMed ID: 8805642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of allelic exclusion permits autoreactive B cells to escape deletion.
    Iliev A; Spatz L; Ray S; Diamond B
    J Immunol; 1994 Oct; 153(8):3551-6. PubMed ID: 7930577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice.
    Bloom DD; Davignon JL; Cohen PL; Eisenberg RA; Clarke SH
    J Immunol; 1993 Feb; 150(4):1579-90. PubMed ID: 8432994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independently derived IgG anti-DNA autoantibodies from two lupus-prone mouse strains express a VH gene that is not present in most murine strains.
    Gangemi RM; Singh AK; Barrett KJ
    J Immunol; 1993 Nov; 151(9):4660-71. PubMed ID: 8409427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of spontaneous nephrotropic anti-laminin antibodies in an autoimmune MRL-lpr/lpr mouse.
    Foster MH; Sabbaga J; Line SR; Thompson KS; Barrett KJ; Madaio MP
    J Immunol; 1993 Jul; 151(2):814-24. PubMed ID: 8335911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both Sm and DNA are selecting antigens in the anti-Sm B cell response in autoimmune MRL/lpr mice.
    Retter MW; Cohen PL; Eisenberg RA; Clarke SH
    J Immunol; 1996 Feb; 156(3):1296-306. PubMed ID: 8558010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residues that mediate DNA binding of autoimmune antibodies.
    Radic MZ; Mackle J; Erikson J; Mol C; Anderson WF; Weigert M
    J Immunol; 1993 Jun; 150(11):4966-77. PubMed ID: 8496598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the structure, regulation, and pathogenic potential of anti-dsDNA antibodies.
    Spatz L; Iliev A; Saenko V; Jones L; Irigoyen M; Manheimer-Lory A; Gaynor B; Putterman C; Bynoe M; Kowal C; Kuo P; Newman J; Diamond B
    Methods; 1997 Jan; 11(1):70-8. PubMed ID: 8990091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice.
    Erikson J; Radic MZ; Camper SA; Hardy RR; Carmack C; Weigert M
    Nature; 1991 Jan; 349(6307):331-4. PubMed ID: 1898987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
    Chen Y; Stollar BD
    J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells.
    Lazdina U; Cao T; Steinbergs J; Alheim M; Pumpens P; Peterson DL; Milich DR; Leroux-Roels G; Sällberg M
    J Virol; 2001 Jul; 75(14):6367-74. PubMed ID: 11413303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-binding antibodies from viable motheaten mutant mice: implications for B cell tolerance.
    Westhoff CM; Whittier A; Kathol S; McHugh J; Zajicek C; Shultz LD; Wylie DE
    J Immunol; 1997 Sep; 159(6):3024-33. PubMed ID: 9300728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.